vs
Absci Corp（ABSI）与Ametek（AME）财务数据对比。点击上方公司名可切换其他公司
Ametek的季度营收约是Absci Corp的3074.5倍（$2.0B vs $650.0K）。Ametek净利率更高（19.9% vs -4548.0%，领先4567.9%）。Ametek同比增速更快（13.4% vs -2.3%）。Ametek自由现金流更多（$527.3M vs $-29.3M）。过去两年Ametek的营收复合增速更高（7.3% vs -14.9%）
Absci Corp是一家结合合成生物学与人工智能技术的生物技术企业，为全球制药及生物制药合作伙伴提供集成式蛋白质工程解决方案，加速抗体、治疗性蛋白等新型生物候选药物的研发，助力满足未被覆盖的临床医疗需求。
AMETEK Inc.是美国跨国综合企业，为全球知名的电子仪器及机电设备设计商与制造商，总部位于美国，在全球范围内设有超过150个运营站点，业务覆盖多个国家和地区，为各行业客户提供高性能的相关产品及配套解决方案。
ABSI vs AME — 直观对比
营收规模更大
AME
是对方的3074.5倍
$650.0K
营收增速更快
AME
高出15.7%
-2.3%
净利率更高
AME
高出4567.9%
-4548.0%
自由现金流更多
AME
多$556.6M
$-29.3M
两年增速更快
AME
近两年复合增速
-14.9%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $650.0K | $2.0B |
| 净利润 | $-29.6M | $398.6M |
| 毛利率 | — | 36.0% |
| 营业利润率 | -4775.5% | 25.3% |
| 净利率 | -4548.0% | 19.9% |
| 营收同比 | -2.3% | 13.4% |
| 净利润同比 | -2.0% | 2.9% |
| 每股收益（稀释后） | $-0.19 | $1.73 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABSIAME
| Q4 25 | $650.0K | $2.0B | ||
| Q3 25 | $378.0K | $1.9B | ||
| Q2 25 | $593.0K | $1.8B | ||
| Q1 25 | $1.2M | $1.7B | ||
| Q4 24 | $665.0K | $1.8B | ||
| Q3 24 | $1.7M | $1.7B | ||
| Q2 24 | $1.3M | $1.7B | ||
| Q1 24 | $898.0K | $1.7B |
净利润ABSIAME
| Q4 25 | $-29.6M | $398.6M | ||
| Q3 25 | $-28.7M | $371.4M | ||
| Q2 25 | $-30.6M | $358.4M | ||
| Q1 25 | $-26.3M | $351.8M | ||
| Q4 24 | $-29.0M | $387.3M | ||
| Q3 24 | $-27.4M | $340.2M | ||
| Q2 24 | $-24.8M | $337.7M | ||
| Q1 24 | $-22.0M | $310.9M |
毛利率ABSIAME
| Q4 25 | — | 36.0% | ||
| Q3 25 | — | 36.3% | ||
| Q2 25 | — | 35.8% | ||
| Q1 25 | — | 36.1% | ||
| Q4 24 | — | 36.6% | ||
| Q3 24 | — | 36.0% | ||
| Q2 24 | — | 36.0% | ||
| Q1 24 | — | 34.1% |
营业利润率ABSIAME
| Q4 25 | -4775.5% | 25.3% | ||
| Q3 25 | -7977.2% | 25.8% | ||
| Q2 25 | -5293.9% | 26.0% | ||
| Q1 25 | -2351.9% | 26.3% | ||
| Q4 24 | -4477.3% | 26.6% | ||
| Q3 24 | -1698.7% | 26.1% | ||
| Q2 24 | -2104.0% | 25.8% | ||
| Q1 24 | -2616.7% | 24.0% |
净利率ABSIAME
| Q4 25 | -4548.0% | 19.9% | ||
| Q3 25 | -7594.2% | 19.6% | ||
| Q2 25 | -5155.0% | 20.2% | ||
| Q1 25 | -2234.6% | 20.3% | ||
| Q4 24 | -4358.3% | 22.0% | ||
| Q3 24 | -1610.7% | 19.9% | ||
| Q2 24 | -1948.8% | 19.5% | ||
| Q1 24 | -2447.1% | 17.9% |
每股收益（稀释后）ABSIAME
| Q4 25 | $-0.19 | $1.73 | ||
| Q3 25 | $-0.20 | $1.60 | ||
| Q2 25 | $-0.24 | $1.55 | ||
| Q1 25 | $-0.21 | $1.52 | ||
| Q4 24 | $-0.26 | $1.67 | ||
| Q3 24 | $-0.24 | $1.47 | ||
| Q2 24 | $-0.22 | $1.45 | ||
| Q1 24 | $-0.22 | $1.34 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $144.3M | $458.0M |
| 总债务越低越好 | — | $2.3B |
| 股东权益账面价值 | $189.4M | $10.6B |
| 总资产 | $216.3M | $16.1B |
| 负债/权益比越低杠杆越低 | — | 0.21× |
8季度趋势，按日历期对齐
现金及短期投资ABSIAME
| Q4 25 | $144.3M | $458.0M | ||
| Q3 25 | $152.5M | $439.2M | ||
| Q2 25 | $38.0M | $619.7M | ||
| Q1 25 | $47.0M | $399.0M | ||
| Q4 24 | $112.4M | $374.0M | ||
| Q3 24 | $38.2M | $396.3M | ||
| Q2 24 | $42.9M | $396.6M | ||
| Q1 24 | $58.8M | $373.8M |
总债务ABSIAME
| Q4 25 | — | $2.3B | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $4.0M | $2.1B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ABSIAME
| Q4 25 | $189.4M | $10.6B | ||
| Q3 25 | $210.3M | $10.5B | ||
| Q2 25 | $173.4M | $10.4B | ||
| Q1 25 | $198.8M | $10.0B | ||
| Q4 24 | $179.1M | $9.7B | ||
| Q3 24 | $201.3M | $9.6B | ||
| Q2 24 | $221.5M | $9.3B | ||
| Q1 24 | $240.1M | $9.0B |
总资产ABSIAME
| Q4 25 | $216.3M | $16.1B | ||
| Q3 25 | $245.0M | $16.2B | ||
| Q2 25 | $209.9M | $15.3B | ||
| Q1 25 | $232.4M | $14.9B | ||
| Q4 24 | $213.6M | $14.6B | ||
| Q3 24 | $235.2M | $14.8B | ||
| Q2 24 | $255.5M | $14.8B | ||
| Q1 24 | $274.9M | $14.9B |
负债/权益比ABSIAME
| Q4 25 | — | 0.21× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.02× | 0.22× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-29.2M | $584.3M |
| 自由现金流经营现金流 - 资本支出 | $-29.3M | $527.3M |
| 自由现金流率自由现金流/营收 | -4505.4% | 26.4% |
| 资本支出强度资本支出/营收 | 15.8% | 2.9% |
| 现金转化率经营现金流/净利润 | — | 1.47× |
| 过去12个月自由现金流最近4个季度 | $-94.2M | $1.7B |
8季度趋势，按日历期对齐
经营现金流ABSIAME
| Q4 25 | $-29.2M | $584.3M | ||
| Q3 25 | $-25.0M | $440.9M | ||
| Q2 25 | $-16.9M | $359.1M | ||
| Q1 25 | $-21.8M | $417.5M | ||
| Q4 24 | $-17.0M | $550.0M | ||
| Q3 24 | $-20.7M | $487.2M | ||
| Q2 24 | $-16.8M | $381.4M | ||
| Q1 24 | $-17.9M | $410.2M |
自由现金流ABSIAME
| Q4 25 | $-29.3M | $527.3M | ||
| Q3 25 | $-26.0M | $420.0M | ||
| Q2 25 | $-17.1M | $329.8M | ||
| Q1 25 | $-21.9M | $394.5M | ||
| Q4 24 | $-17.0M | $498.3M | ||
| Q3 24 | $-20.8M | $460.9M | ||
| Q2 24 | $-17.2M | $360.0M | ||
| Q1 24 | — | $382.6M |
自由现金流率ABSIAME
| Q4 25 | -4505.4% | 26.4% | ||
| Q3 25 | -6876.5% | 22.2% | ||
| Q2 25 | -2883.0% | 18.5% | ||
| Q1 25 | -1854.5% | 22.8% | ||
| Q4 24 | -2554.4% | 28.3% | ||
| Q3 24 | -1221.6% | 27.0% | ||
| Q2 24 | -1352.4% | 20.8% | ||
| Q1 24 | — | 22.0% |
资本支出强度ABSIAME
| Q4 25 | 15.8% | 2.9% | ||
| Q3 25 | 254.5% | 1.1% | ||
| Q2 25 | 37.6% | 1.6% | ||
| Q1 25 | 2.1% | 1.3% | ||
| Q4 24 | 3.5% | 2.9% | ||
| Q3 24 | 2.8% | 1.5% | ||
| Q2 24 | 26.2% | 1.2% | ||
| Q1 24 | 0.0% | 1.6% |
现金转化率ABSIAME
| Q4 25 | — | 1.47× | ||
| Q3 25 | — | 1.19× | ||
| Q2 25 | — | 1.00× | ||
| Q1 25 | — | 1.19× | ||
| Q4 24 | — | 1.42× | ||
| Q3 24 | — | 1.43× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 1.32× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ABSI
暂无分部数据
AME
| Transferred At Point In Time | $1.1B | 54% |
| Electronic Instruments Group | $620.1M | 31% |
| Transferred Over Time | $294.6M | 15% |
